Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

NMDA receptor antagonists potentiate opioid-induced analgesia in animals

March 4, 1999

Second-generation tetracyclines afford significant neuroprotection in stroke model

March 4, 1999

Dual 5-HT reuptake inhibitors/5-HT1A antagonists patented by Lundbeck

March 4, 1999

Mediolanum's AChE inhibitor falls by the wayside

March 4, 1999

ReQuip effective in restless legs syndrome

March 4, 1999

Biochemical and pharmacological profile of new MAO-A inhibitor: 2614W94

March 3, 1999

Alertec approved in Canada for treatment of narcolepsy

March 3, 1999

Janssen confirms lubeluzole no longer under development

March 3, 1999

FDA issues complete response letter for Rebif BLA

March 3, 1999

German launch announced for Merck's migraine drug

March 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...